Next Article in Journal
Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents
Previous Article in Journal
Helium Ion Therapy for Advanced Juvenile Nasopharyngeal Angiofibroma
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Liu et al. Current Understanding of Microbiomes in Cancer Metastasis. Cancers 2023, 15, 1893

Clinical Biobank Center, Microbiome Medicine Center, Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China
*
Author to whom correspondence should be addressed.
Cancers 2024, 16(11), 1994; https://doi.org/10.3390/cancers16111994
Submission received: 17 October 2023 / Accepted: 27 November 2023 / Published: 24 May 2024
(This article belongs to the Section Cancer Metastasis)
In the original publication [1], the authors wish to revise the arrow of the epithelial–mesenchymal transition (EMT) in the schematic representation of the mechanism of suppressing cancer metastasis in Figure 1, which was overlooked in the final proofreading.
In Figure 1, in the schematic representation of the mechanism of suppressing cancer metastasis by suppressing the epithelial–mesenchymal transition (EMT), E-calmodulin should be upregulated instead of downregulated. Therefore, an upward arrow should be used instead of a downward arrow.
This is the corrected figure:
Figure 1. Microbiome affects cancer metastasis through epithelial–mesenchymal transition (EMT). Fn, Fusobacterium nucleatum; ADH1B, alcohol dehydrogenase 1B; TGFBR2, transforming growth factor β receptor 2; IPA, indolepropionic acid. Figure created with BioRender.com on 14 January 2023.
Figure 1. Microbiome affects cancer metastasis through epithelial–mesenchymal transition (EMT). Fn, Fusobacterium nucleatum; ADH1B, alcohol dehydrogenase 1B; TGFBR2, transforming growth factor β receptor 2; IPA, indolepropionic acid. Figure created with BioRender.com on 14 January 2023.
Cancers 16 01994 g001
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.

Reference

  1. Liu, J.; Luo, F.; Wen, L.; Zhao, Z.; Sun, H. Current Understanding of Microbiomes in Cancer Metastasis. Cancers 2023, 15, 1893. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Liu, J.; Luo, F.; Wen, L.; Zhao, Z.; Sun, H. Correction: Liu et al. Current Understanding of Microbiomes in Cancer Metastasis. Cancers 2023, 15, 1893. Cancers 2024, 16, 1994. https://doi.org/10.3390/cancers16111994

AMA Style

Liu J, Luo F, Wen L, Zhao Z, Sun H. Correction: Liu et al. Current Understanding of Microbiomes in Cancer Metastasis. Cancers 2023, 15, 1893. Cancers. 2024; 16(11):1994. https://doi.org/10.3390/cancers16111994

Chicago/Turabian Style

Liu, Jiaqi, Feiyang Luo, Liyan Wen, Zhanyi Zhao, and Haitao Sun. 2024. "Correction: Liu et al. Current Understanding of Microbiomes in Cancer Metastasis. Cancers 2023, 15, 1893" Cancers 16, no. 11: 1994. https://doi.org/10.3390/cancers16111994

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop